NCT06454240: An ongoing trial by Sanofi
This trial is ongoing. It must report results 9 months, 3 weeks from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06454240 |
|---|---|
| Title | A Randomized Phase 2, Double-blind, Placebo-controlled, Parallel-group, 2-arm Study to Assess the Efficacy, Safety, and Tolerability of Subcutaneous Lunsekimig in Adult Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | July 17, 2024 |
| Completion date | Jan. 29, 2026 |
| Required reporting date | Jan. 29, 2027, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | March 26, 2026 |
| Days late | None |